Pharma & Life Sciences

Is it a must-win for Biogen over Forward Pharma?

Featured image source: https://www.pexels.com/photo/dark-purple-black-medicine-119931/

Biogen has had a news-breaking start to the year, first with Michael Vounatsos taking over as the CEO of the company; and second, with Vounatsos announcing a payout of $1.25 billion to Forward Pharma to settle a patent licensing agreement. Vounatos has been quoted in the media as saying this will help strengthen Biogen’s intellectual property and protect its drug […]

Decoding India’s Section 3(d) Pharma Controversy

Source: http://tabletkinaodchudzanie.bblog.pl/i/blog/users/158355/files/Image/14.jpg

India owns the third largest pharmaceutical industry in the world in terms of volume and is the 14th largest in terms of value. It has joined hands with those of China, Brazil, Russia and 13 other countries to create a pool of pharmerging countries. This pool is expected to contribute nearly 50% of the world’s annual pharmaceutical market growth. While India […]

Deuterated Drugs set to Explode in Patent Battles

Source: http://www.farmaceuticas.com.br/wp-content/uploads/2014/11/formula.jpg

Circa 2015 created a flutter of excitement in the pharmaceutical world when scientists unearthed patents filed in the 1970s and found it supporting the claims of a modified drug manufactured in the USA. The SD-809 drug is a deuterated drug that is awaiting the FDA’s approval to get on shelves and help cure palsy in patients affected by Huntington’s chorea. […]

Zika: Another Epidemic That Could Have Been Avoided

Featured image source: https://pixabay.com/p-49141/?no_redirect

The Zika virus outbreak in South America has created a medical emergency around the continent and beyond. Genetically modified mosquitoes designed and developed in the laboratories to fight dengue are being held responsible for this epidemic. The pharmaceutical industry appears weapon-less to tackle this disease. Lack of vaccines and mechanisms to combat it appears to be the major concern. Drug […]

Copy Cats set to Reduce Healthcare Costs

Featured image source: http://bit.ly/1QExS1C

It’s a new trend that’s gaining momentum in the arena of medication. There are a host of copycat medicines that are coming our way, which are set to revolutionize medicine costs, offering more customized treatment. Chemically synthesized drugs like choles­terol-lowering Lipitor, the one-time phar­maceutical sales leader, gained a host of replicas churned out by generic drug com­panies once patent protection […]